How far can this ponzi really go? Will biotech change the world forever? Is it really different this time?
Short it after it breaks the curve. This could go up for another 42%, who knows how many greater fool are there still..
• BIS UltraShort Nasdaq Biotechnology 2x: etfdb.com
• BIB Ultra Nasdaq Biotechnology 2x: etfdb.com
• LABD Daily S&P Biotech Bear 3x...
The Nasdaq Biotechnology rallied more than 4% on last week to a new all-time high. The NBI has seen two big plunges this year, including a 10% correction in April. Despite these zigzags, the trend is up. Earlier on Thursday, the Nasdaq crossed its previous intraday high set in March 2000.
Now near the 4000 points, expect a correction in the next days for returning...
It ought to correct overbought Nasdaq Biotechnology Index:
The Nasdaq Biotech index has grown about 50 percent since Yellen's valuation comments. Superarando por mucho el desempeño de los indices composite y S&P500, this boom is due primarily to the pharmaceutical companies who have monopolized the attention of investors the past few months, beyond the debate of...
Well, that's the million dollar question. The multi-year move, unequivocally, has been one for the books, but propensity has shifted to the downside. Momentum name valuations are getting clipped, seemingly, on a daily basis, as investor de-risking broadens and continues heading into the psychological "sell in May" period. Included are several key support levels to...
In aggregate, the impressive move in biotechnology has truly been one for the books, but is it sustainable? Although the fundamentals remain intact (biotech is a growth story and, indubitably, one that's here to stay), I think it is fair to assume that we could see a pullback of at least 10% at some point in the near future. What goes up, must come down. The...
